Covered recipient · General Payments record
JOSEPH WILLIAM BEETS
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$3,289.36
- Reported across 208 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $472.90 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $332.74 | 26 |
| Regeneron Healthcare Solutions, Inc. | $31.67 | 1 |
| Phathom Pharmaceuticals, Inc. | $27.80 | 2 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $21.28 | 1 |
| Celgene Corporation | $19.16 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $13.72 | 1 |
| Janssen Biotech, Inc. | $13.33 | 1 |
| IRONWOOD PHARMACEUTICALS, INC | $13.20 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $11.90 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103300172 | CMS |
| ABBVIE INC. | $12.35 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103300174 | CMS |
| ABBVIE INC. | $10.89 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103300176 | CMS |
| ABBVIE INC. | $2.86 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103300178 | CMS |
| ABBVIE INC. | $20.36 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103300180 | CMS |
| ABBVIE INC. | $18.82 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103300182 | CMS |
| ABBVIE INC. | $9.67 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103300184 | CMS |
| ABBVIE INC. | $17.20 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103300186 | CMS |
| ABBVIE INC. | $2.88 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103300188 | CMS |
| ABBVIE INC. | $3.97 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103300190 | CMS |
| ABBVIE INC. | $9.44 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103300192 | CMS |
| ABBVIE INC. | $9.99 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103300194 | CMS |
| ABBVIE INC. | $34.10 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103300196 | CMS |
| ABBVIE INC. | $7.37 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103300198 | CMS |
| ABBVIE INC. | $18.63 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103300200 | CMS |
| ABBVIE INC. | $16.98 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103300202 | CMS |
| ABBVIE INC. | $6.96 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103300204 | CMS |
| ABBVIE INC. | $1.01 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103300206 | CMS |
| ABBVIE INC. | $8.83 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103300208 | CMS |
| ABBVIE INC. | $25.46 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103300210 | CMS |
| ABBVIE INC. | $14.74 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103300212 | CMS |
| ABBVIE INC. | $7.45 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103300214 | CMS |
| ABBVIE INC. | $20.18 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103300216 | CMS |
| ABBVIE INC. | $14.82 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103300218 | CMS |
| ABBVIE INC. | $8.75 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103300220 | CMS |
| ABBVIE INC. | $17.13 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103300222 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $13.72 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146962368 | CMS |
| Celgene Corporation | $19.16 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101169526 | CMS |
| IRONWOOD PHARMACEUTICALS, INC | $13.20 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153751998 | CMS |
| Janssen Biotech, Inc. | $13.33 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078632581 | CMS |
| Phathom Pharmaceuticals, Inc. | $14.25 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151039544 | CMS |
| Phathom Pharmaceuticals, Inc. | $13.55 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151039546 | CMS |
| Regeneron Healthcare Solutions, Inc. | $31.67 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114007527 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $21.28 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153683279 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.